Latest News in the pharma Industry

Top Stories

SCM Pharma Wins Science & Technology Award

SCM Pharma Wins Science & Technology Award

30 Mar 2012

SCM Pharma was named the winner of the Science & Technology Award at the North East Business Award for the UK’s Northumberland and Tyneside region.

Read more 
Seaside Therapeutics Obtains Patent for Autism Drug Candidate STX209

Seaside Therapeutics Obtains Patent for Autism Drug Candidate STX209

29 Mar 2012

Seaside Therapeutics has obtained a US patent covering its lead product candidate STX209 for the improvement of social and communication functions in autism spectrum disorders.

Read more 
Bayer HealthCare & Tsinghua Expand Drug Discovery Pact

Bayer HealthCare & Tsinghua Expand Drug Discovery Pact

28 Mar 2012

Scientists from Tsinghua University will work with Bayer scientists to solve the 3D protein structure of biological molecular targets as a basis for new drug discovery projects.

Read more 
Impax & Tolmar Ink Supply Pact

Impax & Tolmar Ink Supply Pact

28 Mar 2012

The two firms have signed a multi-product deal for the development, supply and distribution of alternative dosage form products.

Read more 
Novasep Opens New Facility in China

Novasep Opens New Facility in China

28 Mar 2012

Novasep will expand purification process solutions for biopharmaceuticals including recombinant proteins, peptides and biosimilars, including monoclonal antibodies and insulin, and pharmaceuticals such as optical isomers and certain anti-cancer APIs.

Read more 
Roche Once Again Extends Illumina Bid

Roche Once Again Extends Illumina Bid

28 Mar 2012

The hostile approach, which is valued at approximately $5.7bn, will now give shareholders until April 20 to accept an offer of $44.50 per share.

Read more 
Daiichi Sankyo Announces New Global Corporate Slogan

Daiichi Sankyo Announces New Global Corporate Slogan

26 Mar 2012

The new slogan 'Passion for Innovation. Compassion for Patients.' will be rolled from April 1, 2012 via corporate advertisements, corporate websites and so on.

Read more 
Anaphore Acquires RuiYi in China

Anaphore Acquires RuiYi in China

26 Mar 2012

The acquisition of RuiYi allows Anaphore to access the substantial scientific expertise, capital and potential new collaboration opportunities in the Chinese pharmaceutical marketplace.

Read more 
Ablynx Extends Nanobody Pact with BI

Ablynx Extends Nanobody Pact with BI

26 Mar 2012

Ablynx has extended nanobody alliance with Boehringer Ingelheim.

Read more 
UCB Pharma with Oxford University to Develop Drugs for Serious Diseases

UCB Pharma with Oxford University to Develop Drugs for Serious Diseases

22 Mar 2012

UCB will fund the collaboration with ?3.6 million over three years to develop medicines that will treat serious diseases in immunology and neurology.

Read more 
Abbott Announces Name for New Drug Company

Abbott Announces Name for New Drug Company

22 Mar 2012

The name for its new research-based pharmaceutical company is derived from a combination of Abbott and 'vie,' which references the Latin root 'vi' meaning life.

Read more 
Astellas Withdraws Application for Extension of Qutenza Indication

Astellas Withdraws Application for Extension of Qutenza Indication

21 Mar 2012

The company stated that it decided to withdraw the application based on the CHMP's view that the data provided do not allow the Committee to conclude on a positive benefit-risk balance.

Read more